The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-6-amino-2-((S)-2-((2R,3R)-2-amino-3-methylpentanamido)-3-phenylpropanamido)-N-(4-benzoylphenyl)hexanamide ID: ALA4544648
PubChem CID: 14082554
Max Phase: Preclinical
Molecular Formula: C34H43N5O4
Molecular Weight: 585.75
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@@H](C)[C@@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)Nc1ccc(C(=O)c2ccccc2)cc1
Standard InChI: InChI=1S/C34H43N5O4/c1-3-23(2)30(36)34(43)39-29(22-24-12-6-4-7-13-24)33(42)38-28(16-10-11-21-35)32(41)37-27-19-17-26(18-20-27)31(40)25-14-8-5-9-15-25/h4-9,12-15,17-20,23,28-30H,3,10-11,16,21-22,35-36H2,1-2H3,(H,37,41)(H,38,42)(H,39,43)/t23-,28+,29+,30-/m1/s1
Standard InChI Key: LQCSAVLURRTZMD-UJLGHMMASA-N
Molfile:
RDKit 2D
43 45 0 0 0 0 0 0 0 0999 V2000
6.5913 -6.3988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3065 -5.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0215 -7.2239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0215 -6.3988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3065 -5.1592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0215 -4.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5913 -4.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5913 -3.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7366 -5.9842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4516 -6.3988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1626 -5.1592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1626 -5.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4516 -7.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1626 -8.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1626 -7.6343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8795 -7.2228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5963 -7.6343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5963 -8.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8795 -8.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8777 -6.3988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5928 -5.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3078 -7.2239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3078 -6.3988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5928 -5.1592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3078 -4.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3078 -3.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0229 -3.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0229 -2.6840 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0229 -5.9842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7364 -6.3944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7358 -7.2166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4485 -7.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1614 -7.2139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1573 -6.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4440 -5.9803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8754 -7.6232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8780 -8.4461 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5868 -7.2094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2973 -7.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0082 -7.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0060 -6.3859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2870 -5.9768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5791 -6.3922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 9 1 0
12 20 1 0
23 29 1 0
1 2 1 0
2 4 1 6
4 3 2 0
2 5 1 0
5 6 1 1
5 7 1 0
7 8 1 0
9 10 1 0
10 12 1 0
12 11 2 0
10 13 1 6
13 15 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 1 0
21 23 1 0
23 22 2 0
21 24 1 1
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
33 36 1 0
36 37 2 0
36 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 42 1 0
42 43 2 0
43 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 585.75Molecular Weight (Monoisotopic): 585.3315AlogP: 3.57#Rotatable Bonds: 16Polar Surface Area: 156.41Molecular Species: BASEHBA: 6HBD: 5#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.08CX Basic pKa: 10.20CX LogP: 4.10CX LogD: 0.63Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.13Np Likeness Score: -0.14
References 1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA.. (2020) Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding., 63 (4): [PMID:31658420 ] [10.1021/acs.jmedchem.9b01060 ]